Evolent Health Company Top Insiders

EVH Stock  USD 11.25  0.34  2.93%   
Evolent Health's insiders are aggressively selling. The analysis of the overall insider sentiment regarding Evolent Health suggests that almost all insiders are panicking. Evolent Health employs about 4.7 K people. The company is managed by 30 executives with a total tenure of roughly 118 years, averaging almost 3.0 years of service per executive, having 156.67 employees per reported executive.
Seth Blackley  CEO
Chief Executive Officer, Co-Founder, Director
Frank Williams  Chairman
Co-Founder, CEO, Director and Chairman of Nominating and Governance Committee

Evolent Health's Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-08-22Seth BlackleyDisposed 187904 @ 30View
2023-12-05Seth BlackleyDisposed 141000 @ 26.54View
Monitoring Evolent Health's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.

Evolent Health's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Evolent Health's future performance. Based on our forecasts, it is anticipated that Evolent will maintain a workforce of under 4700 employees by December 2024.
 
Yuan Drop
 
Covid

Evolent Health's latest congressional trading

Congressional trading in companies like Evolent Health, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Evolent Health by those in governmental positions are based on the same information available to the general public.
2020-05-29Representative Greg GianforteAcquired $50K to $100KVerify

Evolent Health Management Team Effectiveness

The current Return On Tangible Assets is estimated to decrease to -0.15. The current Return On Capital Employed is estimated to decrease to -0.04. As of now, Evolent Health's Other Assets are increasing as compared to previous years. The Evolent Health's current Other Current Assets is estimated to increase to about 73.6 M, while Total Current Assets are projected to decrease to under 354.3 M. Evolent Health's management efficiency ratios could be used to measure how well Evolent Health manages its routine affairs as well as how well it operates its assets and liabilities.
The current Common Stock Shares Outstanding is estimated to decrease to about 70.4 M. The current Net Loss is estimated to decrease to about (18.1 M)

Evolent Health Workforce Comparison

Evolent Health is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 11,590. Evolent Health totals roughly 4,700 in number of employees claiming about 41% of equities under Health Care industry.
The company has Net Profit Margin of (0.03) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.03) %, which entails that for every $100 of revenue, it lost $0.03.

Evolent Health Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Evolent Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Evolent Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Evolent Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2023-12-01
0.25
2
8
 283,000 
 433,490 
2023-09-01
0.1429
1
7
 4,386 
 50,482 
2023-06-01
0.6522
15
23
 481,432 
 903,009 
2023-03-01
0.5152
17
33
 1,546,302 
 1,959,501 
2022-12-01
0.3
3
10
 295,000 
 590,000 
2022-09-01
0.125
1
8
 17,247 
 159,955 
2022-06-01
9.0
9
1
 50,076 
 3,860 
2022-03-01
0.4167
10
24
 453,809 
 966,247 
2021-12-01
0.3846
5
13
 183,405 
 390,000 
2021-09-01
0.4762
20
42
 175,318 
 402,716 
2021-06-01
1.1818
13
11
 119,417 
 125,052 
2021-03-01
7.0
7
1
 164,590 
 0.00 
2020-09-01
0.5
1
2
 10,000 
 20,000 
2020-06-01
1.3333
8
6
 268,114 
 99,530 
2020-03-01
6.0
6
1
 530,219 
 0.00 
2019-09-01
0.4
2
5
 22,200 
 80,222 
2018-09-01
0.3103
9
29
 245,440 
 735,559 
2018-06-01
0.5625
9
16
 58,672 
 3,189,979 
2018-03-01
6.0
12
2
 2,486,174 
 4,812,898 
2017-09-01
0.3077
4
13
 27,700 
 114,507 
2017-06-01
0.403
27
67
 8,034,433 
 20,455,695 
2017-03-01
0.6071
17
28
 4,713,444 
 11,742,278 
2016-09-01
0.5238
11
21
 2,037,829 
 10,427,023 
2016-06-01
1.0
1
1
 8,183 
 0.00 
2015-12-01
2.0
2
1
 12,954 
 0.00 
2015-06-01
0.0227
1
44
 2,000 
 13,768,760 

Evolent Health Notable Stakeholders

An Evolent Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Evolent Health often face trade-offs trying to please all of them. Evolent Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Evolent Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Dan McCarthyCEO PresidentProfile
Seth BlackleyChief Executive Officer, Co-Founder, DirectorProfile
Frank WilliamsCo-Founder, CEO, Director and Chairman of Nominating and Governance CommitteeProfile
Nicholas McGraneExecutive Vice President of Corporate PerformanceProfile
John JohnsonChief Financial OfficerProfile
Thomas PetersonChief Operating OfficerProfile
Steve TutewohlChief Operating OfficerProfile
Bridget DuffyIndependent DirectorProfile
Bruce FeltIndependent DirectorProfile
Cheryl ScottLead Independent DirectorProfile
David FarnerDirectorProfile
Diane HolderDirectorProfile
Michael DAmatoIndependent DirectorProfile
Kim KeckIndependent DirectorProfile
Jonathan JDGeneral OfficerProfile
Robert CruzChief OfficerProfile
John MDChief OfficerProfile
Tunde SotundeIndependent DirectorProfile
MAAA FSAChief OfficerProfile
Emily RaffertyChief OfficerProfile
M DuffyIndependent DirectorProfile
Craig BarbaroshIndependent DirectorProfile
Jonathan WeinbergGeneral CounselProfile
Aammaad ShamsInterim Principal Accounting Officer and Corporate ControllerProfile
Jessica SomersSr DevelProfile
Seth FrankVice RelationsProfile
Mark MannionSenior FinanceProfile
Peter GruaIndependent DirectorProfile
Kali BeyahChief OfficerProfile
Jessica WhiteChief OfficerProfile

About Evolent Health Management Performance

The success or failure of an entity such as Evolent Health often depends on how effective the management is. Evolent Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Evolent management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Evolent management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.14)(0.15)
Return On Capital Employed(0.04)(0.04)
Return On Assets(0.04)(0.04)
Return On Equity(0.11)(0.10)

Evolent Health Workforce Analysis

Traditionally, organizations such as Evolent Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Evolent Health within its industry.

Evolent Health Manpower Efficiency

Return on Evolent Health Manpower

Revenue Per Employee417.9K
Revenue Per Executive65.5M
Net Loss Per Employee24.1K
Net Loss Per Executive3.8M
Working Capital Per Employee2K
Working Capital Per Executive314.4K

Complementary Tools for Evolent Stock analysis

When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities